Efficacy and tolerability of Dianex in type 2 diabetes mellitus: A non randomized, open label non-coqmparative study

Medical Journal of Malaysia

Volumn 60, Issue 2, 2005, Pages 204-211

  Sudha, V ^a   Bairy, K L ^b   Shashikiran, U ^a   Sachidananda, A ^a   Jayaprakash, B ^a   Shalini, S ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

^b AIMST UNIVERSITY   (Malaysia)

Author keywords

Dianex; Non randomized; Open label; Type 2 diabetes mellitus

Indexed keywords

DIANEX; GLYCOSYLATED HEMOGLOBIN; HERBACEOUS AGENT; INSULIN; LIVER ENZYME; UNCLASSIFIED DRUG; HEMOGLOBIN VARIANT; HEMOGLOBIN, GLYCERATED; PLANT EXTRACT;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INDIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY FUNCTION TEST; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; BLOOD; CLINICAL TRIAL; FOLLOW UP; METABOLISM; MIDDLE AGED; SAFETY; TREATMENT OUTCOME;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS, ABNORMAL; HUMANS; MALE; MIDDLE AGED; PLANT EXTRACTS; SAFETY; TREATMENT OUTCOME;

EID: 24944581714     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. King, H., Aubert, RE., & Herman, WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-431.
2. Ramachandran A, Snehalatha C, Latha E, Vijay V and Viswanathan M; Rising prevalence of NIDDM in urban population in India. Diabetologica 1997; 40: 232-7.
3. Mustaffa BE. Diabetes mellitus in Asia: an increasing health care burden. Med Dig 1998; 16: 5-9.
4. John PC. Historical background. Textbook of Diabetes, 2nd ed., vol. I. London: Blackwell Science, 1997: 101.
5. Udupa N. Effect of Dianex on blood sugar, serum lipids and blood pressure in rats. Report submitted to Apex Laboratories [PVT] Ltd Chennai, India 2000.
6. Kay KH, Nicolas W, Robert L, Sheila B, Suzy O, Ailsa W, Nicolas D. Glycated hemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition. BMJ 2001; 322: 15.
7. McCance, DR., Hanson, RL., Charles, M-A., Jacobsson, LTH., Pettitt, DJ., Bennett, PH., et al. Comparison of tests for glycated hemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes, BMJ 1994; 308: 1323-32.
8. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologica. 1985; 28: 412-19.
9. Groop LC, Pelkonen R, Koskimies S, Bottazzo GF, Doniach D: Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes. Diabetes Care 1986; 9: 129-33.